Voxel SA
WSE:VOX
Net Margin
Voxel SA
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
PL |
V
|
Voxel SA
WSE:VOX
|
1.8B PLN |
18%
|
|
US |
![]() |
Cigna Corp
NYSE:CI
|
80B USD |
2%
|
|
US |
C
|
Cigna Group
XMUN:CGN
|
67.9B EUR |
2%
|
|
US |
![]() |
CVS Health Corp
NYSE:CVS
|
76.6B USD |
1%
|
|
DE |
![]() |
Fresenius Medical Care AG
XMUN:FME
|
26.5B EUR |
3%
|
|
DE |
![]() |
Fresenius SE & Co KGaA
XETRA:FRE
|
23.7B EUR |
2%
|
|
US |
![]() |
Laboratory Corporation of America Holdings
NYSE:LH
|
22.2B USD |
6%
|
|
US |
![]() |
Quest Diagnostics Inc
NYSE:DGX
|
18.9B USD |
9%
|
|
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
13.2B EUR |
3%
|
|
US |
![]() |
Hims & Hers Health Inc
NYSE:HIMS
|
12.9B USD |
9%
|
|
US |
![]() |
DaVita Inc
NYSE:DVA
|
11.2B USD |
7%
|
Voxel SA
Glance View
Voxel SA engages in the provision of medical services. The company is headquartered in Krakow, Woj. Malopolskie and currently employs 546 full-time employees. The company went IPO on 2011-10-11. The company provides services in the fields of diagnostic imaging, teleradiology and outsourcing, as well as information technology (IT) systems for hospitals and diagnostic centers. As of December 31, 2011, the Company operated two subsidiaries, 95.24%-owned Alteris SA and wholly owned CDO Sp. z o.o. On November 7, 2012, the Company sold its entire stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Voxel SA's most recent financial statements, the company has Net Margin of 18.2%.